Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy. - Guven,H.; Gilljam,M.; Chambers,B.J.; Ljunggren,H.G.; Christensson,B.; Kimby,E.; Dilber,M.S. (Leukemia, 2003)